(Q73608394)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10742563%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

IgG antiganglioside antibodies in Guillain-Barré syndrome with bulbar palsy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10742563%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

main subject

Guillain–Barré syndrome

1 reference

1 reference

H Yoshino

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10742563%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H Harukawa

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10742563%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Asano

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10742563%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10742563%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10742563%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10742563%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10742563%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

195-201

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10742563%20AND%20SRC:MED&resulttype=core&format=json

Assessment of current diagnostic criteria for Guillain-Barré syndrome

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

Serum antibodies to gangliosides in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

IgG anti-GT1a antibodies which do not cross react with GQ1b ganglioside in a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

Antiganglioside antibody in patients with Guillain-Barré syndrome who show bulbar palsy as an initial symptom

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

GM1b is a new member of antigen for serum antibody in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

Experimental sensory neuropathy induced by sensitization with ganglioside GD1b.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

Ganglioside characterization of a cell line displaying motor neuron-like phenotype: GM2 as a possible major ganglioside in motor neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

Two species of antiganglioside antibodies in a patient with a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

Anti-GQ1b and anti-GT1a IgG antibodies in a patient with acute demyelinating polyradiculoneuropathy without ophthalmoplegia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

Unusual clinical variants and signs in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

IgM deposits at nodes of Ranvier in a patient with amyotrophic lateral sclerosis, anti-GM1 antibodies, and multifocal motor conduction block

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

Ophthalmoplegic and lower cranial nerve variants merge into each other and into classical Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

Abnormal glycosphingolipid metabolism in the nervous system of galactosialidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

IgG antibody against GM1, GD1b and asialo-GM1 in chronic polyneuropathy following Mycoplasma pneumoniae infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barré syndrome and Fisher's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900280-5

7 January 2021

10.1016/S0165-5728(99)00280-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10742563%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference